[Long-term survival after nasal NK/T cell lymphoma].

The nasal NK/T cell lymphoma is a rare, extranodal non-Hodgkin lymphoma in western civilizations, which has poor prognosis. The Epstein-Barr virus can be detected in tumor cells in nearly all cases. There are no definite treatment guidelines in our days. There is no significant difference in survival between radiotherapy and chemotherapy according to Asian studies. In this case study we show our diagnostic procedures, our treatment options and we present the summary of this illness based on the data found in the literature.

[1]  K. Chang,et al.  Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. , 2005, Blood.

[2]  Y. Niibe,et al.  Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases. , 2005, Anticancer research.

[3]  Yao-chang Chen,et al.  Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas , 1997, British journal of haematology.

[4]  Shulian Wang,et al.  Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  C. Kim,et al.  Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy. , 2005, Japanese journal of clinical oncology.

[6]  T. Yoshino,et al.  Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. , 1998, Blood.

[7]  J. Chan,et al.  Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Jaffe,et al.  Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. , 1996, The American journal of surgical pathology.